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Abstract
Objective: Unmet health care needs require additional care resources to achieve
optimal patient well-being. In this nationwide study we examined associations
between a number of risk factors and unmet needs after treatment among women
with breast cancer, while taking into account their health care practices. We expected
that more care use would be associated with lower levels of unmet needs.
Methods: A multicenter, prospective, observational design was employed. Women
with primary breast cancer completed questionnaires 6 and 15 months post-diagno-
sis. Medical data were retrieved from medical records. Direct and indirect associa-
tions between sociodemographic and clinical risk factors, distress, care use, and
unmet needs were investigated with structural equation modeling.
Results: Seven hundred forty-six participants completed both questionnaires
(response rate 73.7%). The care services received were not negatively associated with
the reported levels of unmet needs after treatment. Comorbidity was associated with
higher physical and daily living needs. Higher age was associated with higher health
system-related and informational needs. Having had chemotherapy and a mastec-
tomy were associated with higher sexuality needs and breast cancer-specific issues,
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respectively. A higher level of distress was associated with higher levels of unmet
need in all domains.
Conclusions: Clinicians may use these results to timely identify which women are at
risk of developing specific unmet needs after treatment. Evidence-based, cost-
effective (online) interventions that target distress, the most influential risk factor,
should be further implemented and disseminated among patients and clinicians.
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1 | BACKGROUND
Breast cancer is the most frequently diagnosed cancer among women
worldwide.1 Thanks to the introduction of early detection programs
and increasingly successful treatments, the number of breast cancer
survivors keeps rising. Yet, this positive development entails an
increasing number of survivors with disease- and treatment-related
problems. Many report fatigue, psychological distress, poor physical
fitness, motion restriction, lymphedema, sleep problems, cognitive
problems, and menopausal symptoms.2-5
Many women with breast cancer receive medical, paramedical,
psychosocial, or complementary care to cope with these problems, up
to more than 10 years after diagnosis.6 For most women, the received
resources are sufficient.7 However, a considerable proportion of
women with breast cancer express an unmet need for support, indi-
cating that they would like additional help. The prevalence of specific
needs may reach up to 70%. The highest needs are generally found in
the psychological and health system-related and informational
domain, with fear of the cancer spreading or recurring being the most
prevalent.8
To ensure that these needs are adequately addressed, clinicians
might benefit from knowing which women with breast cancer are
most at risk of developing unmet needs. A considerable number of
studies addressed this topic. A systematic review found that, for
instance, younger women, with advanced stage breast cancer, treated
with chemotherapy, or those who experience a higher level of dis-
tress, report increased unmet needs. Risk factors may differ between
domains. For example, women with a higher level of education report
greater unmet need in the sexuality, and/or health system-related and
informational domains, while women with a lower level of education
generally report greater unmet need in the psychological and/or
patient care and support domains.8
These insights show promise in identifying the women with
breast cancer most in need for additional support. However, more
research is warranted. First, most studies employed cross-sectional
designs to address risk factors of unmet need domains during cancer
treatment, when the levels of unmet needs are highest. Far less stud-
ies examined risk factors of need domains shortly after treatment,
when a greater number of patients experience unmet needs.9 Patients'
need for support may rise as they may miss regular contact with
health care professionals and/or experience treatment-induced side
effects.10 Therefore, more prospective studies regarding risk factors
of specific unmet need domains in the post-treatment phase are
required.11
Furthermore, health care needs, by definition, refer to problems
that require an action or additional care resources to achieve optimal
well-being.8,9,12 This implies that received care resources and one's
level of unmet need may be associated.13,14 Yet, to the best of our
knowledge, the extent to which different types of received health
care, such as medical, paramedical, or psychosocial care, influence the
relation between risk factors and specific unmet need domains, has
not been investigated.
The current study aims to extend existing insights by examining
associations between risk factors and unmet needs of women with
breast cancer post-treatment, while taking into account varying types
of care use. We hypothesized that higher levels of health care use are
associated with lower levels of remaining unmet needs, thus that care
use helps fulfill existing needs.
Based on the literature, we included age, educational level, can-
cer stage, types of treatment, and distress as sociodemographic,
clinical, and psychosocial risk factors.8 We additionally included
type of care insurance and comorbidity as possible risk factors that
deserve more research attention.14,15 Patients may refrain from
physical or psychological treatment if their insurance does not fully
cover the costs. Consequently, they may experience higher levels
of unmet need in the physical and daily living and psychological
domains. Having one or more comorbid disorders may especially
influence unmet need in the physical and daily living domain.
Finally, we included previous psychosocial treatment as a potential
risk factor. Breast cancer patients with a history of mental illness
are at higher risk of developing cancer-related distress.16 If not ade-
quately addressed, they may experience higher levels of psychologi-
cal need over time.
Most of the included sociodemographic and clinical factors are
also known risk factors for a higher level of distress.17 As such, dis-
tress might be a more proximal risk factor, and possibly a mediating
factor between the other risk factors and patients' levels of unmet
needs. Therefore, we further hypothesized that the included
sociodemographic and clinical factors influence unmet needs directly
and indirectly through distress.
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2 | METHODS
2.1 | Participants and procedure
Women with primary breast cancer diagnosed up to 6 months earlier
in one of nine hospitals in the Netherlands (ie, six academic hospitals,
two community hospitals, and one comprehensive cancer center)
were eligible for the study, regardless of type of treatment. Patients
were excluded if they were not literate in Dutch, younger than
18 years, and/or had a prognosis of 3 months or less.
Eligible patients were identified by their oncologist, cancer nurse, or
nurse practitioner during a hospital visit. The clinician informed the
patient about the study and asked whether she would consider participa-
tion. Subsequently, the investigator invited interested patients to partici-
pate by telephone or e-mail. Participating centers could exclude patients
who were already participating in other studies. A more detailed descrip-
tion of the study procedure has previously been published.7,18
Our aim was to include at least 900 participants, a sufficient number
for testing multiple correlations, given the number of predictors. This
number would suffice even when domain scores would be included sep-
arately, and taking into account a drop-out rate of 20%.19,20
2.2 | Design
The study had a multicenter, prospective, observational design. Partic-
ipants completed a self-report questionnaire at 6 months (time win-
dow 5 to 7 months) and 15 months (time window 14 to 16 months)
post-diagnosis. Medical data were retrieved from medical records. As
the study was observational in nature, it did not require formal review
according to the institutional review boards of participating hospitals,
in accordance with Dutch legal regulations.
Sociodemographic factors were assessed at 6 months post-diag-
nosis. Distress, health care use and needs were assessed at 6 and
15 months post-diagnosis. As we were interested in identifying risk
factors of unmet needs over time, after adjusting for received care, we
included the data on sociodemographic, clinical, and psychosocial risk
factors from the 6 months post-diagnosis assessment, and the data on
care use and needs from the 15 months post-diagnosis assessment.
2.3 | Sociodemographic and clinical factors
Age at diagnosis, educational level (8 response categories, including
the option “other,” see the legend of Table 2), type of health insurance
(5 response categories: no health insurance, basic package, basic pack-
age and additional package without dental insurance, basic package
and dental insurance, basic package with additional and dental
insurance), number of comorbid conditions (17 response categories,
including the options “none” and “other”),21 and previous use of
psychosocial services (yes/no) were assessed through self-report.
Cancer stage (via pTNM-classification)22 and types of treatment were
retrieved from medical records.
2.4 | Distress
Psychosocial distress was assessed with the validated Dutch version
of the single item Distress Thermometer.23,24 The Thermometer is a
visual analog scale, that measures the level of distress in the past
week (score 0 “no distress at all” to 10 “extreme distress”).
2.5 | Health care use
Health care use was assessed with a 24-item questionnaire.7,18,21 The
questionnaire measures how often in the past 3 months patients used
specific types of medical (eg, visits to a surgeon), psychosocial (eg,
visits to a psychologist), paramedical (eg, visits to a physical therapist),
and supplementary care services (eg, use of paid child care) (response
categories: 0, 1, 2, 3, 4, 5, more than 5 times). The legend of Table 2
provides an overview of the included services. We calculated a sum
score for each type of care.
2.6 | Health care needs
Health care needs were assessed with the 34-item Supportive Care
Needs Survey (SCNS-SF34),25 and the 8-item SCNS breast cancer-
specific module.26 The SCNS measures patients' perceived needs over
the past month in the psychological, health system-related and infor-
mational, physical and daily living, patient care and support, and sexu-
ality domain (five response categories: no need, met need, some need,
moderate need, high need). The additional module addresses breast
cancer-specific needs, for example, related to experiencing
lymphedema.
We calculated a Likert sum score for each domain, excluding the
category “met need,” such that a higher domain score indicated a
higher level of unmet need for help (range 0 “no need” to 3 “high
need”). This was an adaptation of the standard scoring procedure.
Cronbach's alpha coefficient in our study ranged from 0.86 to 0.96 for
the SCNS-SF34 subscales and was 0.81 for the breast cancer-specific
module. Finally, we transformed the scores to a scale ranging from
0 to 100 in order to facilitate comparisons across scores.
2.7 | Data analyses
Associations between the included risk factors, care use, and unmet
needs over time were examined with structural equation modeling
(SEM).27 SEM has the ability to include multiple independent and
dependent variables in one model, thus enabling simultaneous analysis
of all hypothesized associations. Missing values ranged from 0% for
age and the treatment-related variables to 9.5% for the unmet need
score in the patient care and support domain. The full information
maximum likelihood estimation method28 was used to take missing
data into account.29 SEs were corrected for deviations from normality
by use of the Huber-White estimator.30
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Our model included direct effects of all sociodemographic and clini-
cal factors on level of distress, care use, and needs factors and of all care
use factors on all care need variables. Residual covariances were allowed
between health care use or health care need variables. The resulting
specified model was a saturated model with zero degrees of freedom.
The reported standardized parameters (ß's) can be interpreted as
effect size indices. Values of 0.10, 0.30, and 0.50 were considered to
indicate small, medium, and large effect sizes for categorical variables,
and values of 0.20, 0.50, and 0.80 for continuous variables. For the
reported R-squares—the percentages of explained variance in distress,
care use, and needs—values of 2%, 13%, and 26% were considered to
reflect small, medium, and large effect sizes, respectively.31
Descriptive analyses were performed with SPSS version 22. For
SEM, the lavaan package in the R software system for statistical com-
puting was used.32
3 | RESULTS
3.1 | Sample
Of 1353 women with breast cancer assessed, 1263 women were eli-
gible, and 1012 agreed to participate. The analyses for this study
included the 746 women who completed both questionnaires (73.7%
of participants) (Figure 1). Most women were diagnosed with stage
1 or 2 invasive breast cancer, and were treated with lumpectomy and
radiotherapy. Over 60% had one or more comorbid conditions
(Table 1).
Participants did not differ significantly in age (groups based on
median split, P > .10), cancer stage (chi-square, P > .10), or distress
score 6 months post-diagnosis (P > .10) from nonrespondents, that is,
from women who were approached by the investigator, but could not
F IGURE 1 Flowchart
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be reached or declined to participate. Participants who only com-
pleted the first questionnaire at 6 months post-diagnosis (n = 111) did
not differ significantly in age (chi-square, P > .10), cancer stage (chi-
square, P > .10), or distress score (t tests, P > .10) from those who
completed both questionnaires (n = 746).
3.2 | Risk factors of distress
Patients reported on average a distress level of 3.93 (SD = 2.67) at
6 months post-diagnosis. Younger age (ß = −.18), having had chemo-
therapy (ß = .43), comorbidity (ß = .17), and psychosocial treatment
before the breast cancer diagnosis (ß = .29) were found to be associ-
ated with a higher level of distress (P < .05). The predictors together
explained 12.3% of variance, reflecting a small effect size (Table 2).
3.3 | Risk factors of unmet needs
Patients reported the highest level of unmet need in the physical and
daily living domain (M = 13.40, SD = 20.09), followed by the psycho-
logical domain (M = 12.85, SD = 19.63), the health system-related
and informational domain (M = 11.01, SD = 20.53), and the patient
care and support domain (M = 7.25, SD = 15.59) at 15 months post-
diagnosis. The lowest unmet needs were related to breast cancer-
specific (M = 6.72, SD = 13.40) and sexuality issues (M = 5.90,
SD = 15.58).
A number of risk factors were found to be associated with
higher levels of unmet needs, while taking into account types of care
received (P < .05). Comorbidity (ß = .15), a higher level of distress
(ß = .37), more medical care use (ß = .08), and psychosocial care use
(ß = .10) were significantly associated with a higher level of unmet
need in the physical and daily living domain. A higher level of dis-
tress (ß = .14), more medical care use (ß = .08), and less paramedical
care use (ß = −.07) were significantly associated with a higher level
of unmet need related to patient care and support. Furthermore, a
higher level of distress (ß = .30) and more frequent use of psychoso-
cial care use (ß = .19) significantly predicted a higher level of unmet
needs related to psychological issues, and along with chemotherapy
also significantly predicted unmet needs related to sexuality (ß = .27
for chemotherapy, ß = .13 for distress and ß = .15 for psychosocial
care use). Higher age (ß = .11) and a higher level of distress (ß = .22)
significantly predicted a higher level of unmet health system-related
and informational needs. Finally, having a mastectomy (ß = .69), a
higher level of distress (ß = .20), and medical care use (ß = .20) signif-
icantly predicted a higher level of unmet breast cancer-specific
needs.
The risk factors explained between 8.0% of variance for unmet
need in the domain of care and support and 24.1% of variance for
unmet physical and daily living needs, indicating small to medium
effect sizes (Table 2).
4 | DISCUSSION
This prospective, nationwide study identified risk factors of unmet
needs among women with breast cancer after treatment, while taking
into account their global reports of received care practices. Of the
included sociodemographic, clinical, and psychosocial risk factors,
higher age, having one or more comorbid disorders, having had che-
motherapy or a mastectomy, and patients' level of distress were found
to be significant direct risk factors.
The data, generally, did not support our hypothesis that women's
reports of received care services are negatively related to their unmet
needs. There were even some small positive associations, for example,
TABLE 1 Sample characteristics (n = 746)
Characteristics Total samplea
Sociodemographic factors
Age at diagnosis (median, range) 58 (24-83)
Educational level (n, %)b
Low 345 (46.3)
Intermediate 185 (24.8)
High 215 (28.9)
Health insurance
No health insurance 2 (0.3)
Basic package 83 (11.4)
Basic and additional package 645 (88.4)
Clinical factors
Cancer stage at diagnosis (n, %)
TIS: carcinoma in situ 103 (13.9)
Invasive early stage (T1/T2) 620 (83.6)
Invasive late stage (T3/T4) 19 (2.6)
Type of surgery (n, %)
Lumpectomy 630 (84.5)
Mastectomy 105 (14.1)
Lumpectomy and mastectomy 9 (1.2)
No lumpectomy or mastectomy 2 (0.3)
Radio and/or chemotherapy (n, %)
Radiotherapy only 470 (63.0)
Chemotherapy only 24 (3.2)
Radio- and chemotherapy 198 (26.5)
No radio- or chemotherapy 54 (7.2)
Other types of treatment (n, %)
Hormonal therapy (yes) 258 (34.6)
Immunotherapy (yes) 32 (4.3)
Comorbid conditions (n, %; yes) 457 (62.2)
Previous use of psychosocial services (n, %; yes) 167 (22.5)
aPresented percentages are valid percentages, missing values excluded.
bEducational level was categorized as low (no education, elementary
school, low level vocational education, or intermediate level high school),
intermediate (intermediate level vocational education, or high level high
school), and high (high level vocational education, or college or university).
LO-FO-WONG ET AL. 5
TABLE 2 Predictors of distress, health care use, and unmet needs at 15 months post-diagnosis*
Factora,c ß Est.b SE* Z-value P(>|z|) R2
Level of distress 12.30%
Age −.177 0.044 −4.028 .000
Educational level 1 .015 0.091 0.161 .872
Educational level 2 −.072 0.086 −0.838 .402
Type of health insurance .043 0.111 0.390 .696
Cancer stage −.072 0.113 −0.637 .524
Mastectomy −.003 0.146 −0.021 .983
Chemotherapy .431 0.098 4.417 .000
Radiotherapy −.073 0.161 −0.455 .649
Hormonal therapy .061 0.085 0.717 .473
Comorbidity .174 0.077 2.255 .024
Psychosocial treatment before diagnosis .290 0.083 3.491 .000
Unmet needs
Physical and daily living needs 24.10%
Age −.023 0.040 −0.574 .566
Educational level 1 .087 0.087 1.000 .317
Educational level 2 .042 0.080 0.530 .596
Type of health insurance −.108 0.103 −1.050 .294
Cancer stage .164 0.088 1.860 .063
Mastectomy .252 0.139 1.812 .070
Chemotherapy −.056 0.102 −0.556 .578
Radiotherapy .174 0.159 1.097 .273
Hormonal therapy −.104 0.082 −1.268 .205
Comorbidity .146 0.073 1.999 .046
Psychosocial treatment before diagnosis .174 0.090 1.934 .053
Level of distress .372 0.041 9.126 .000
Medical care use .083 0.038 2.162 .031
Psychosocial care use .095 0.048 1.959 .050
Paramedical care use −.048 0.031 −1.526 .127
Supplementary service use .086 0.062 1.393 .164
Patient care and support needs 8.00%
Age −.033 0.051 −0.643 .520
Educational level 1 .030 0.090 0.334 .739
Educational level 2 .060 0.087 0.689 .491
Type of health insurance −.092 0.123 −0.744 .457
Cancer stage .138 0.084 1.635 .102
Mastectomy .372 0.217 1.718 .086
Chemotherapy .124 0.112 1.102 .270
Radiotherapy .221 0.214 1.033 .302
Hormonal therapy −.140 0.091 −1.535 .125
Comorbidity .063 0.075 0.846 .398
Psychosocial treatment before diagnosis .157 0.107 1.460 .144
Level of distress .137 0.039 3.486 .000
Medical care use .083 0.042 1.962 .050
Psychosocial care use .073 0.041 1.804 .071
Paramedical care use −.069 0.034 −2.039 .041
(Continues)
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TABLE 2 (Continued)
Factora,c ß Est.b SE* Z-value P(>|z|) R2
Supplementary service use −.020 0.039 −0.514 .607
Psychological needs 19.60%
Age .004 0.042 0.098 .922
Educational level 1 −.166 0.089 −1.870 .061
Educational level 2 −.088 0.080 −1.096 .273
Type of health insurance −.078 0.114 −0.684 .494
Cancer stage .014 0.097 0.144 .885
Mastectomy .278 0.174 1.594 .111
Chemotherapy .048 0.110 0.434 .664
Radiotherapy .215 0.188 1.143 .253
Hormonal therapy −.126 0.087 −1.441 .150
Comorbidity .035 0.071 0.484 .628
Psychosocial treatment before diagnosis .193 0.099 1.944 .052
Level of distress .301 0.041 7.317 .000
Medical care use .076 0.044 1.718 .086
Psychosocial care use .192 0.045 4.254 .000
Paramedical care use −.049 0.049 −1.005 .315
Supplementary service use .003 0.045 0.074 .941
Sexuality needs 11.70%
Age −.058 0.043 −1.349 .177
Educational level 1 −.063 0.089 −0.714 .475
Educational level 2 .057 0.094 0.607 .544
Type of health insurance −.122 0.115 −1.063 .288
Cancer stage .015 0.094 0.154 .878
Mastectomy .209 0.188 1.113 .266
Chemotherapy .269 0.126 2.142 .032
Radiotherapy −.060 0.215 −0.281 .778
Hormonal therapy −.170 0.095 −1.784 .074
Comorbidity .015 0.074 0.201 .841
Psychosocial treatment before diagnosis .158 0.109 1.446 .148
Level of distress .130 0.038 3.434 .001
Medical care use .027 0.039 0.694 .488
Psychosocial care use .148 0.053 2.772 .006
Paramedical care use −.032 0.039 −0.821 .412
Supplementary service use −.006 0.046 −0.131 .896
System-related and informational needs 9.10%
Age .111 0.046 2.418 .016
Educational level 1 −.069 0.097 −0.709 .478
Educational level 2 −.121 0.086 −1.406 .160
Type of health insurance −.222 0.136 −1.630 .103
Cancer stage .026 0.107 0.248 .805
Mastectomy .256 0.177 1.443 .149
Chemotherapy .131 0.117 1.126 .260
Radiotherapy .006 0.209 0.028 .978
Hormonal therapy −.100 0.095 −1.058 .290
Comorbidity .092 0.073 1.252 .211
(Continues)
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between medical care use and the reported level of breast cancer-
specific needs (Table 2). Perhaps the lack of negative associations
between use and unmet needs domains, after controlling for women's
level of distress, indicates that some health care services did not
completely fulfill patients' expectations. The positive associations may
reflect that some patients are prone to keep seeking and using care.
Alternatively, it could be that more received care does decrease one's
levels of unmet care needs, but that this may only become apparent
with a longer period of follow-up.
With regard to the sociodemographic factors, there is strong evi-
dence that younger age is associated with a higher number of unmet
needs after cancer treatment.11,33 Additionally, two studies among
early cancer survivors reported associations between younger age
and specific unmet need domains, namely the patient care and sup-
port, and the relationship/sexuality domain.11 In contrast, our study
showed a small but significant direct association between higher age
and higher levels of unmet need in the health system-related and
informational domain. While an overall effect of age on unmet needs
has been established, we conclude that this might mask varying
effects on separate underlying unmet needs domains. One explana-
tion for our finding is that older patients are more likely to experience
more comorbid or physical problems in addition to their cancer diag-
nosis, which requires additional support and information. Also, older
cancer patients may have more difficulty with processing and recalling
provided information due to decreasing cognitive and sensory func-
tions.34 In addition to a direct effect, we would like to highlight that
TABLE 2 (Continued)
Factora,c ß Est.b SE* Z-value P(>|z|) R2
Psychosocial treatment before diagnosis .087 0.096 0.901 .368
Level of distress .223 0.045 4.905 .000
Medical care use .070 0.053 1.329 .184
Psychosocial care use .039 0.036 1.085 .278
Paramedical care use −.021 0.055 −0.378 .705
Supplementary service use .000 0.048 0.009 .993
Breast cancer-specific needs 18.60%
Age .050 0.043 1.147 .251
Educational level 1 −.014 0.092 −0.148 .882
Educational level 2 −.069 0.079 −0.878 .380
Type of health insurance −.188 0.119 −1.588 .112
Cancer stage .095 0.085 1.124 .261
Mastectomy .693 0.254 2.733 .006
Chemotherapy −.069 0.107 −0.647 .517
Radiotherapy .043 0.279 0.155 .877
Hormonal therapy −.056 0.091 −0.611 .541
Comorbidity −.075 0.079 −0.946 .344
Psychosocial treatment before diagnosis .082 0.093 0.882 .378
Level of distress .197 0.044 4.434 .000
Medical care use .199 0.066 3.021 .003
Psychosocial care use .055 0.043 1.259 .208
Paramedical care use −.000 0.049 −0.000 1.000
Supplementary service use .040 0.052 0.771 .441
aWith the exception of age, distress, health care use, and needs, all the variables were entered as dummy variables (educational level 1: low vs
intermediate; educational level 2: intermediate vs high; type of insurance: basic vs basic and additional package; cancer stage: ductal carcinoma in situ vs
invasive tumor; all types of treatment: no vs yes; comorbidity: no vs one or more comorbid conditions). Immunotherapy was not included as a predictor
given the small percentage of participants who received this type of treatment (n = 32).
bThe reported standardized parameters (ß's) can be interpreted as effect size indices. That is, for the continuous predictors age, distress, health care use,
and needs, values of .20, .50, and .80 are indicative of small, medium, respectively large effect sizes. For categorical predictors values of .10, .30, and .50
are considered to indicate small, medium, large effect sizes, respectively.
cMedical care use included visits to a surgeon, radiation oncologist, medical oncologist, breast cancer nurse, anesthesiologist, general practitioner, plastic
surgeon, sexologist, gynecologist, clinical geneticist, occupational physician, or lymphedema therapist. Psychosocial care use included visits to a
psychologist or psychotherapist, social worker, psychiatrist, or spiritual care provider. Paramedical care use included visits to a physical therapist, dietician,
or ergotherapist. Supplementary service care use included use of paid child care, home care/nurse at home, domestic help, a support group, or a group
rehabilitation program.
*Printed in bold: P < .05.
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age was found to be a relevant indirect risk factor of all unmet need
domains, through distress.
Our study showed nonsignificant associations between patients'
type of care insurance and their levels of unmet needs in varying
domains. Hopefully, this is an indication that coverage is not an access
barrier to receiving satisfactory care just after breast cancer
treatment—at least in countries such as the Netherlands where having
basic medical insurance is obligatory. The influence of patients' care
insurance on their levels of unmet need will differ between care sys-
tems. We encourage researchers to further investigate the influence
of access-related risk factors on varying unmet need domains directly
following treatment and in the survival phase.
Regarding the included clinical factors, the existing evidence on
the association between cancer stage and unmet needs after treat-
ment is inconclusive. Two studies with a cancer-specific samples (ie,
women with gynecologic or endometrial cancer) found a significant
association between stage and unmet needs, as measured around
4 years after diagnosis, while one study did not. Comparable studies
with breast cancer,15,33,35-37 other, or mixed cancer samples11 often
lacked information on the cancer stage at diagnosis, and did not exam-
ine its influence on separate unmet need domains post-treatment.
Only 3% of our participants were diagnosed with cancer stage 3 or
4, which meant that we could not examine the influence of later can-
cer stages on women's levels of unmet needs. We were able to estab-
lish that women with carcinoma in situ do not differ in level of unmet
needs after treatment from women with invasive, mostly early stage,
breast cancer.
Having had chemotherapy was previously found to be the most
relevant treatment-related risk factor, and was generally associated
with several unmet need domains after a breast cancer diagnosis (ie,
the psychological, physical/daily living, patient care and support, and
the sexuality domain). Most of these earlier studies addressed the
treatment phase.8 Based on our results, chemotherapy may especially
have longer lasting direct effects on unmet need in the sexuality
domain. This finding might be breast cancer-specific.11 The result is
consistent with the widely held belief that both physicians and
patients can be reluctant to openly discuss sexuality problems due to
cancer or its treatment. In fact, we found that 10% of our sample
would have liked more contact with a sexologist 12 to 15 months
after diagnosis.7 In general, it appears that the influence of relevant
clinical risk factors on unmet needs becomes more domain-specific
with time after diagnosis. Accordingly, there was a strong association
between having had a mastectomy and breast-cancer specific needs,
and between comorbidity and physical and daily living needs after
treatment, as hypothesized.
The most relevant risk factor of unmet needs after treatment is
distress. A higher level of distress was found to significantly, directly
influence unmet needs after breast cancer treatment across
domains. This result is consistent with previous studies, regarding
distress and anxiety.33,36,37 Our findings extend the literature
by establishing the enduring influence of breast cancer-related dis-
tress on specific unmet need domains over time, especially physical
and daily living, psychological, and health system-related and
informational needs. Importantly, our findings indicate that distress
may be an important mediator between sociodemographic and clini-
cal risk factors (ie, age, comorbidity, psychosocial treatment before
diagnosis, especially chemotherapy) and unmet needs, as previously
suggested.33
4.1 | Study limitations
The number of visits to care providers was assessed by self-report.
These results may be influenced by recall bias, leading to possible
under- or overestimation of actual care practices. However, self-
assessment allowed us to also assess the use of nonmedical types of
care use, which are not standardly registered in medical files. Another
study limitation is that many participants were recruited from radio-
therapy departments. Therefore, women with breast cancer who do
not receive radiotherapy, a minority, were underrepresented in our
sample. A previous study based on data from a Dutch population-
based, regional cancer registry indicated that 17% of the women with
breast cancer received systemic therapy without radiotherapy.38 Fur-
thermore, we were not able to gather information about women who
declined to be approached for this study. Therefore, we could not
determine our sample's representativeness in that regard. There was,
however, no indication of a sample bias resulting from loss to
follow-up.
Strengths of our study include its multicenter, prospective, design,
its nationwide character, and large sample size. We addressed a key
period in the disease trajectory that warrants further investigation of
risk factors in relation to survivors' unmet needs. Indeed, thanks to
the large sample size, we were able to simultaneously examine multi-
ple risk factors of separate domains of unmet needs in concurrence
with varying types of health care use of women with breast cancer.
To our knowledge, this is the first study to have done so.
4.2 | Future research suggestions
To ensure appropriate and cost-effective utilization of care services,
the influence of health care use on varying domains of unmet needs
post-treatment and in the survival phase deserves further attention.
We recommend employing standardized care use39 and needs mea-
surements8 in order to allow comparisons across studies. Given the
increasing number of women with breast cancer, we especially sug-
gest further investigation of the association between psychosocial
care use and unmet needs after a breast cancer diagnosis. Patients
with informational or emotional needs may seek support from psycho-
social providers, while their needs might be satisfied by participating
in support programs, receiving written information, or using low-cost
self-management resources. All future studies on this topic should
include distress as a key risk factor, and preferably also as a mediating
factor. Based on our results, we also recommend examination of types
of comorbid disorders in relation to breast cancer patients' unmet
needs after treatment.
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4.3 | Clinical implications
Clinicians can use these results to identify in a timely manner those
women with breast cancer who are at risk of developing higher levels
of unmet needs after treatment. Distress was found to be the most
relevant risk factor across need domains. Additionally, older women
with breast cancer, with one or more comorbid disorders, who have
had chemotherapy, or who had a mastectomy may have more specific
needs. Higher age was associated with higher health system-related
and informational needs. Comorbidity was associated with higher
physical and daily living needs. Having had chemotherapy and a mas-
tectomy were associated with higher sexuality needs and breast
cancer-specific issues, respectively.
Taking into consideration the growing number of breast cancer
patients and staff shortages, this raises the question how patients'
needs can be adequately met, and perhaps even prevented. Based on
our results and the literature, distress should be targeted as one of
the most significant and modifiable risk factors of unmet needs after
treatment. One possible cost-effective approach would be to address
distress by use of a stepped care program, that is, watchful waiting,
followed by guided self-help, problem-solving therapy, and psycho-
therapy or medication, if needed. Research shows that only a minority
of patients will need the more resource-intensive practices.40
Furthermore, the number of online self-management tools that
target specific needs or distress is steadily growing. However, most of
the promising, evidence-based, tools are not structurally updated and
implemented in practice because of lack of funding after develop-
ment. Also, potential users do not know which tools are available, and
how to evaluate these tools in terms of quality, reliability, and privacy.
Therefore, based on our study results, we also strongly encourage
endeavors to successfully implement and disseminate such low
resource, technology-based aids among patients and clinicians.
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